Biocon Limited has informed the Exchange regarding a press release dated December 07, 2021, titled "Biocon Ltd partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East".
Biocon Limited has informed the Exchange regarding a press release dated December 07, 2021, titled "Biocon Ltd partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East".